Jeffrey F. Eisenberg - Dec 11, 2023 Form 4 Insider Report for Xenetic Biosciences, Inc. (XBIO)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey F. Eisenberg
Stock symbol
XBIO
Transactions as of
Dec 11, 2023
Transactions value $
$0
Form type
4
Date filed
12/13/2023, 05:30 PM
Previous filing
Mar 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIO Stock Options Award $0 +20K $0.00 20K Dec 11, 2023 Common Stock 20K $3.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026.